Monday, January 11th, 2021

CN Bio’s PhysioMimix™ technology receives FDA recognition

Alliance member CN Bio announces how a joint publication with the FDA demonstrates the advantages of their PhysioMimix™ in drug safety and metabolism applications, over standard techniques. This represents the first co-published, peer-reviewed article between a microphysiological system provider and a regulator: